Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Tax drag in dividend ETFs can shave after-tax gains. This quick primer explains the concept and practical implications for investors.
13,081 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investors chasing income may be chasing sky-high yields that hide fragile payouts. Three BDCs illustrate growing payo...
As Hormel gears up for Q1 2026 disclosures, investors want a clear read on margins, demand, and cash flow. This guide...
Two powerhouses sit on opposite ends of the energy spectrum. This guide compares Brookfield Renewable and Enterprise ...
Cash flow from senior housing and warehouse REITs is holding steady even as refinancing costs rise. The payout outloo...
Strategy faces a tough trade-off: use cash to back STRC dividends and buy Bitcoin, or raise fresh capital that dilute...
A perplexing Friday drop in Coca-Cola stock raised questions about cybersecurity, earnings risk, and how to react to ...
Unlock a practical, investor-friendly view of arbor realty (abr) earnings. Learn what drives ABR earnings, how to int...
A $2.9 billion closed-end fund has paid distributions every year since 2000, marking a 26-year streak. Here’s how the...
In May, walmart stock dropped 12% despite solid earnings. This in-depth look breaks down the drivers behind the decli...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
When a blue-chip stock posts a stunning earnings beat, investors flock to understand what comes next. This guide brea...